$MZTI

Marzetti stock price target maintained at $160 by StoneX

StoneX maintained a Buy rating and $160 price target for Marzetti (NASDAQ: MZTI), citing upside potential from its current $100.86 share price. The firm hosted client meetings with Marzetti's management, discussing industry trends, retail performance, and the Bachan's acquisition. StoneX raised its fiscal 2028 estimates, noting the Bachan's brand's growth potential. Marzetti's Q4 results showed mixed performance, with EPS beating estimates but revenue falling short.

Original reporting
Published Oct 8, 2026, 2:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 2:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MZTI
Neutral
medium confidence
Mentioned
$MZTI · $SNEX
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MZTINeutralMed
01

Why it matters

Mixed earnings results and divergent analyst targets may cause short-term volatility in Marzetti's stock.

02

Market read

The earnings and analyst updates could drive short-term price movement in Marzetti and influence foodservice sector sentiment.

03

What to watch

Impact of the recent Bachan’s acquisition on future growth is not fully priced in.

Relevance 6/10Novelty 7/10Timing: post-earnings today

Background

StoneX maintained a $160 price target for Marzetti while DA Davidson lowered its target to $130 after the company's Q4 earnings release.

Company-level read

Ticker impact

$MZTINeutralMedium confidence
Context

Marzetti reported Q4 earnings with an EPS beat but a revenue miss, and analysts updated price targets, affecting its valuation.

Expected impact

potential modest downside as revenue miss may pressure the stock, but upside from target maintenance could support price

Evidence & confidence

Revenue miss outweighs EPS beat, and divergent analyst targets create uncertainty.

Market effects

Foodservice sector may see scrutiny on revenue trends after Marzetti's miss.

U.S. market could see slight pressure on similar foodservice stocks.

Limited global relevance beyond U.S. foodservice industry.

Counterpoint

Despite the revenue miss, strong margin expansion could justify buying at current levels.

Key entities

  • Marzetti Company

    Foodservice company reporting Q4 earnings.

  • StoneX

    Maintained a $160 price target for Marzetti.

  • DA Davidson

    Lowered its price target for Marzetti to $130.

Related articles

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.